6-32828569-T-G
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001290043.2(TAP2):c.*337A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 31) 
 Exomes 𝑓:  0.0000012   (  0   hom.  ) 
 Failed GnomAD Quality Control 
Consequence
 TAP2
NM_001290043.2 3_prime_UTR
NM_001290043.2 3_prime_UTR
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.0210  
Publications
0 publications found 
Genes affected
 TAP2  (HGNC:44):  (transporter 2, ATP binding cassette subfamily B member) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. This gene is located 7 kb telomeric to gene family member ABCB2. The protein encoded by this gene is involved in antigen presentation. This protein forms a heterodimer with ABCB2 in order to transport peptides from the cytoplasm to the endoplasmic reticulum. Mutations in this gene may be associated with ankylosing spondylitis, insulin-dependent diabetes mellitus, and celiac disease. Alternative splicing of this gene produces products which differ in peptide selectivity and level of restoration of surface expression of MHC class I molecules. [provided by RefSeq, Feb 2014] 
TAP2 Gene-Disease associations (from GenCC):
- MHC class I deficiencyInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 31 
GnomAD3 genomes 
Cov.: 
31
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF:  0.00000116  AC: 1AN: 862384Hom.:  0  Cov.: 20 AF XY:  0.00000250  AC XY: 1AN XY: 400332 show subpopulations 
GnomAD4 exome 
Data not reliable, filtered out with message: AS_VQSR
 AF: 
AC: 
1
AN: 
862384
Hom.: 
Cov.: 
20
 AF XY: 
AC XY: 
1
AN XY: 
400332
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
17030
American (AMR) 
 AF: 
AC: 
0
AN: 
4188
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
6144
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
6988
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
18424
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
1144
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
1742
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
777714
Other (OTH) 
 AF: 
AC: 
0
AN: 
29010
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.775 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  Cov.: 31 
GnomAD4 genome 
Cov.: 
31
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.